Psoriasis: Targeted Therapies

Psoriasis: Biologics bring potential for long-term remission off treatment

GENEVA – The results of an extension study of two pivotal secukinumab studies point to a previously…
mdedge.com

TNF inhibitors associated with fewer side effects than methotrexate in children with psoriasis

A sign says Psoriasis.

An international study provides some needed data on the use of systemic treatments and their toxicities in…
mdedge.com

Ixekizumab found superior to ustekinumab in psoriasis at 24 weeks

ORLANDO – At 24 weeks, the IL-17A blocker ixekizumab was superior to the IL-12/IL-23 blocker…
mdedge.com

Jak Inhibition May Ameliorate Pruritus

Last week we reported the results of a metanalysis published in the Journal of Investigative Dermatology showing that certain agents are more effective in…
rheumnow.com